InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: BIOChecker4 post# 174693

Monday, 12/17/2018 11:07:53 AM

Monday, December 17, 2018 11:07:53 AM

Post# of 465814
I agree. I am bullish on the drug itself based on the little I know about how it works and the results so far, but there are a lot more factors outside of Anavex's control -- access to cash being one of them.

It wouldn't surprise me when all is said and done for this to be fully diluted at 100M shares. Granted, if the drug works and is worth $5B or so, then $50/share isn't all that bad of a return -- even from its previous high of $14.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News